Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung.
Siegfried
Jill M
JM
Department of Pharmacology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-1863, USA. siegfriedjm@upmc.edu
Luketich
James D
JD
Stabile
Laura P
LP
Christie
Neil
N
Land
Stephanie R
SR
D000230:Adenocarcinoma / Q000737:chemistry* / Q000401:mortality / Q000473:pathology; D017228:Hepatocyte Growth Factor / Q000032:analysis*; D006801:Humans; D008175:Lung Neoplasms / Q000737:chemistry* / Q000401:mortality / Q000473:pathology; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D015996:Survival Rate
D017228:Hepatocyte Growth Factor